sumatriptan has been researched along with cisapride in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Frölich, D; Göthert, M; Likungu, J; Molderings, GJ | 1 |
Centurión, D; De Vries, P; Heiligers, JP; Saxena, PR; Villalón, CM | 1 |
Crema, F; De Ponti, F | 1 |
Caenepeel, P; Cuomo, R; Janssens, J; Piessevaux, H; Tack, J | 1 |
1 trial(s) available for sumatriptan and cisapride
Article | Year |
---|---|
Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia.
Topics: Adult; Analysis of Variance; Case-Control Studies; Cisapride; Cross-Over Studies; Double-Blind Method; Drinking; Dyspepsia; Energy Intake; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Humans; Male; Satiation; Sensitivity and Specificity; Serotonin Receptor Agonists; Sumatriptan | 2003 |
9 other study(ies) available for sumatriptan and cisapride
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Uptake Inhibitors; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cisapride; Corticosterone; Desipramine; Heart Atria; Humans; Indoles; Ketanserin; Male; Middle Aged; Norepinephrine; Oxadiazoles; Piperidines; Receptors, Presynaptic; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tritium; Tryptamines | 1996 |
Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
Topics: 5-Methoxytryptamine; Animals; Blood Pressure; Cats; Cisapride; Decerebrate State; Heart Rate; Piperidines; Receptors, Serotonin; Recombinant Proteins; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tachycardia | 1997 |
Treatment functional GI disease: the complex pharmacology of serotonergic drugs.
Topics: Buspirone; Cisapride; Gastrointestinal Diseases; Humans; Serotonin Agents; Serotonin Receptor Agonists; Sumatriptan | 2002 |